Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The pharmacokinetics, and clinical and biological effects of MBL replacement therapy in
MBL-deficient children during chemotherapy-induced neutropenia were studied.
Phase:
Phase 2
Details
Lead Sponsor:
Sanquin Sanquin Plasma Products BV
Collaborators:
Landsteiner Foundation Blood Research (LSBR), Amsterdam Landsteiner Foundation for Blood Transfusion